In the latest market activity, Perella Weinberg Partners (Symbol: PWP) has seen its stock price climb above the average analyst 12-month target of $23.88, trading at $23.96 per share. When this milestone is reached, analysts typically face a decision: they can either downgrade the stock’s valuation or raise their target price. The choice may hinge on the company’s recent performance and prospects, prompting analysts to consider if an upward adjustment is warranted.
According to the Zacks coverage universe, four analysts have contributed to the average target for Perella Weinberg Partners. While this average serves as a useful benchmark, it reflects a range of opinions. Some analysts predict a lower target, with one suggesting a price of $13.50, while others foresee a higher target of $28.00. The standard deviation among these estimates stands at $6.98, indicating varying outlooks on the stock’s future.
The purpose of examining the average price target is to utilize the “wisdom of crowds,” combining the insights from multiple analysts. With PWP now trading above the average target of $23.88, investors have an opportunity to evaluate whether this price is merely a stepping stone towards higher valuations or if it signals that the stock might be overvalued. Below is a summary of the current analyst sentiments regarding Perella Weinberg Partners:
Recent PWP Analyst Ratings Breakdown | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
Strong Buy Ratings: | 2 | 2 | 2 | 2 |
Buy Ratings: | 1 | 1 | 1 | 1 |
Hold Ratings: | 0 | 0 | 0 | 0 |
Sell Ratings: | 0 | 0 | 0 | 0 |
Strong Sell Ratings: | 1 | 1 | 1 | 1 |
Average Rating: | 2.25 | 2.25 | 2.25 | 2.25 |
The average rating listed above uses a scale from 1 (Strong Buy) to 5 (Strong Sell). Data in this article comes from Zacks Investment Research via Quandl.com. Stay informed with the latest Zacks research report on PWP — available for free.
The Top 25 Broker Analyst Picks of the S&P 500 »
Additional Readings:
HII Insider Buying
LPTN Insider Buying
Top Ten Hedge Funds Holding SUI
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.